Revenue
2023
2024
2025
2026
Charming Medical Ltd (MCTA)
Price$29.36Cached quote
Net income
2023
2024
2025
2026
Free cash flow
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $2.6M | $3.6M | $3.7M | $3.5M |
| Gross profit | $2.6M | $3.6M | $3.7M | $1.5M |
| Gross margin | 98.65% | 99.57% | 99.69% | 42.31% |
| Operating expenses | $4.8M | $4.8M | $5.0M | $1.8M |
| Operating income | −$29,237 | $1.4M | $1.0M | −$287,498 |
| Operating margin | −1.12% | 38.25% | 27.52% | −8.14% |
| EBITDA | $186,837 | $1.7M | $1.4M | −$189,131 |
| EBITDA margin | 7.14% | 45.51% | 38.20% | −5.36% |
| Net income | −$22,648 | $1.2M | $777,811 | −$305,117 |
| Net profit margin | −0.86% | 33.02% | 21.22% | −8.64% |
| Basic EPSper basic share | $0.00 | $0.08 | $0.05 | -$0.02 |
| Diluted EPSper diluted share | $0.00 | $0.08 | $0.05 | -$0.02 |
Owners
Reported shareholders